BIO-FUNCTION test for predicting transplant risks
This study tests a new lab test called BIO-FUNCTION that may help doctors predict the risk of serious complications after a stem cell transplant. It aims to make transplants safer by identifying patients who might need extra support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled to receive a stem cell transplant or cell therapy (SCTCT).
- You are not pregnant.
- You are not a prisoner.
- You do not have a serious medical or psychiatric condition that would interfere with participating in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at two blood markers to predict the risk of acute graft-versus-host disease after an allogeneic stem cell transplant. If you qualify, your care team may use results to help anticipate and manage complications earlier.
This study looks for proteins or markers in your blood that could help predict a condition called chronic graft-versus-host disease (cGVHD), a common complication after a stem cell transplant from a donor. By joining, you may help doctors detect and treat this condition earlier.
This study is testing a blood test called AlloHeme that may help doctors predict whether your blood cancer will come back after a stem cell transplant. Joining this study could help you and your doctor monitor your recovery more closely.
This study looks at blood tests before and after a donor stem cell transplant to see if certain markers can predict early complications. If you are planning this type of transplant, your participation could help doctors better manage side effects.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This study looks at how certain proteins in the blood around the time of a stem cell transplant may differ based on your blood disease and the type of donor you have. It aims to help doctors understand how to better support patients during stem cell transplants.
Hear when a new Mortality Prediction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.